Eagle Claw Capital Managment, LLC Novartis Ag Call Options Transaction History
Eagle Claw Capital Managment, LLC
- $538 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,350Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.34 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$785 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$651 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$640 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $233B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...